semaglutide wausau wi Semaglutide Microdose Medical Weight Loss

Semaglutide (Wegovy) is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite, whilst ibuprofen is an NSAID that inhibits COX enzymes to reduce pain and inflammation

Within a year, participants regained about two-thirds of the weight they had lost, and said goodbye to some of the improvements in blood pressure, blood sugar and cholesterol they had achieved, according to the landmark STEP 1 extension trial

However, it is recommended to talk to your healthcare provider before starting any high-dose supplements

References Arans C, Edvardsson CE, Shevchouk OT et al (2023) Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats

Cell Mol Neurobiol